By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    How Not to Become a Victim of Medical Scams
    How Not to Become a Victim of Medical Scams
    December 22, 2021
    11 Ways You Can Care for Your Elder Family Members Health
    11 Ways You Can Care for Your Elder Family Members Health
    April 6, 2022
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    August 30, 2022
    Latest News
    The 6 Most Common Injuries Resulting from Motorcycle Accidents
    January 30, 2023
    6 Essential Strategies for Improving Your Medical Practice
    January 25, 2023
    Staying Positive While Living with Mesothelioma
    January 24, 2023
    The Many Health Benefits of Being Outdoors
    January 17, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    health benefits on Marijuana
    California Advocates Cite Health Benefits of Cannabis Legalization
    February 5, 2021
    Is It Right To Opt For A Home Care Service For Elderly Loved Ones?
    April 17, 2020
    Addressing Mental Health Problems in America’s Schools
    July 10, 2018
    Latest News
    Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game
    January 25, 2023
    9 Hospitals That Have Introduced Green Initiatives
    January 25, 2023
    Why a Health Retreat Can Be the Best Medicine
    January 12, 2023
    Best Money-Saving Tips for Health Managers
    January 12, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug
Share
Sign In
Notification Show More
Latest News
investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care
prevent birth injuries
Distressing Birth Injuries and How They Can Be Prevented
Women Health
reduce infertility risks
Lifestyle Choices You Can Make to Minimize Infertility
Pregnancy
stablecoins in healthcare
Stablecoins May Change the Future of Healthcare Billing
News
Personal Injury Healing Tips and Strategies
Personal Injury Healing Tips and Strategies
Health
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug
Technology

OXiGENE Releases Promising Phase Two Data For Lung Cancer Drug

HerinaAyot
Last updated: 2011/06/06 at 7:24 PM
HerinaAyot
Share
3 Min Read
SHARE

OXiGENE (NASDAQ:OXGN) shares rose in pre-market trading on Monday as it announced on the weekend that follow-up results from a phase two study of Zybrestat showed that patients with non-small cell lung cancer had better response and survival rates.

The controlled, randomized trial, called Falcon, tested Zybrestat in combination with three other treatments, compared to the control arm of the study.

OXiGENE (NASDAQ:OXGN) shares rose in pre-market trading on Monday as it announced on the weekend that follow-up results from a phase two study of Zybrestat showed that patients with non-small cell lung cancer had better response and survival rates.

The controlled, randomized trial, called Falcon, tested Zybrestat in combination with three other treatments, compared to the control arm of the study.

More Read

telemedicine business feature benefits

Building Telemedicine System: Features and Tips

5 Ways New Technology is Revolutionizing Health
Medical Code Extraction Using Artificial Intelligence
Maximizing Outcomes Through Effective Patient Engagement Strategies
Telemedicine App Development Cost & Key Features

An updated analysis, conducted roughly 11 months after enrollment of the last patient in June of last year, showed that the Zybrestat arm was well tolerated, with no significant cumulative toxicities. The partial response rate was 56% with Zybrestat, and 36% in the standard therapy arm.

In addition, a subgroup showed “meaningful improvements” in the average time to progression of the disease for patients with poor performance status, or sicker patients, OXiGENE said.

While the median time to progression for the overall patient population was similar in both arms of the study, those with poor performance status had a median time of 9.8 months in the Zybrestat arm, versus 3.8 months for the patients in the control group.

The company said that the suggestion that the Zybrestat combination could be especially beneficial in a sicker patient population should be explored in a larger trial.

“With several clinical trials completed in multiple indications, we now have a large body of data showing the excellent combinability potential of Zybrestat,” said CEO Peter Langecker.

“In addition, this study provides data in non-small cell lung cancer suggesting that Zybrestat may benefit patients with more advanced stages of disease.

“We believe that designing a development plan based on targeting this subgroup of patients could represent a sensible and achievable clinical strategy.”

Zybrestat is a small-molecule drug that targets and collapses tumour cells by depriving them of oxygen, and it is being tested in studies of patients with non-small cell lung cancer, thyroid cancer, ovarian cancer and other clinical trials.

The updated data was presented at the 2011 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois.–Deborah Sterescu

Source

 

TAGGED: lung cancer, medical technology

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
HerinaAyot June 6, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Maine Versus Vermont
Next Article Leave Well Enough Alone

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care January 30, 2023
prevent birth injuries
Distressing Birth Injuries and How They Can Be Prevented
Women Health January 30, 2023
reduce infertility risks
Lifestyle Choices You Can Make to Minimize Infertility
Pregnancy January 30, 2023
stablecoins in healthcare
Stablecoins May Change the Future of Healthcare Billing
News January 30, 2023

You Might also Like

stablecoins in healthcare
News

Stablecoins May Change the Future of Healthcare Billing

January 30, 2023
The Future Of Medicine: How Immunotherapy Is Saving Lives
Technology

The Future Of Medicine: How Immunotherapy Is Saving Lives

January 26, 2023
medical practice and technology advancement
Technology

6 Essential Strategies for Improving Your Medical Practice

January 25, 2023
patient tracking systems for medical staff and innovation
Medical InnovationsTechnology

Patient Tracking Systems: Improving Facilities for Patients and Medical Staff

January 2, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?